Tyscon Pharmaceuticals is a pharmaceutical company offering a wide range of quality, affordable medicines, trusted by healthcare professionals and patients across geographies. Tyscon Pharmaceuticals is one of the new entrants in the Indian Pharmaceutical Industry. Tyscon Pharmaceuticals is founded by a group of Pharmaceutical professionals having vast medico-marketing experience and expertise of the essential domain. Tyscon Pharmaceuticals has been established to become a multi-faceted company participating in a variety of healthcare products.
Tyscon Pharmaceuticals is committed to achieving its vision and mission of becoming an innovation-led national pharmaceutical company and winning over the trust of patients.
Tyscon Pharmaceuticals is a PCD Pharma Company. It has pharma monopoly rights. It introduces the syrups and suspensions which are WHO and GMP Certified. A syrup is an uncrystallizable Saccharine Solution which has a longer shelf life and better quality standard.
TYTRIX-S injection is used for skin and skin structure infections, lower respiratory tract infections, urinary tract infections, bacterial infection, and intraabdominal infections. Ceftriaxone is a third generation Cephalosporin antibiotic. Sulbactam is an irreversible B-lactamase inhibitor.
SCONAC gel maintains the economy of nerves with LINSEED OIL, DICLOFENAC DIETHYLAMINE, METHYL SALICYLATE, and MENTHOL. It reduces tingling and burning sensation during neuropathy. It has the powerful antioxidant that protects neurons from oxidative stress.
PANSCO-40 tablet is used to treat erosive Esophagitis, and other conditions involving excess stomach acid such as Zollinger-Ellison Syndrome. Pantoprazole is a proton pump inhibitor drug used for short-term treatment of erosion and ulceration of the oesophagus caused by gastroesophageal reflux disease.
TYCUF-A syrup brings down the severity of a cough. Ambroxol has the cough-suppressive effect, suppresses all cough parameters. Guaiphenesin decreases sputum viscosity and increases expectoration. Levosalbutamol exhibits greater bronchodilation than salbutamol.
LEVSCO – 500 tablet terminates the power of pathogens. It offers a unique combination of documented efficacy & tolerability. It has a broad range of activity against gram-positive & gram-negative organisms & anaerobes. It demonstrates the high rate of clinical success.